AR074737A1 - Derivados de (4-terc-butilpiperazin-2-il) (piperazin-1-il) metanona-n-carboxamida y composicion farmaceutica que los contiene - Google Patents
Derivados de (4-terc-butilpiperazin-2-il) (piperazin-1-il) metanona-n-carboxamida y composicion farmaceutica que los contieneInfo
- Publication number
- AR074737A1 AR074737A1 ARP090104853A ARP090104853A AR074737A1 AR 074737 A1 AR074737 A1 AR 074737A1 AR P090104853 A ARP090104853 A AR P090104853A AR P090104853 A ARP090104853 A AR P090104853A AR 074737 A1 AR074737 A1 AR 074737A1
- Authority
- AR
- Argentina
- Prior art keywords
- carboxamide
- butilpiperazin
- metanona
- terc
- piperazin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- SRWQVWAIVQXPJY-QGZVFWFLSA-N 4-[(2r)-4-tert-butylpiperazine-2-carbonyl]-n-(4-chloro-3-fluorophenyl)piperazine-1-carboxamide Chemical compound C1N(C(C)(C)C)CCN[C@H]1C(=O)N1CCN(C(=O)NC=2C=C(F)C(Cl)=CC=2)CC1 SRWQVWAIVQXPJY-QGZVFWFLSA-N 0.000 abstract 1
- 102000004497 CCR2 Receptors Human genes 0.000 abstract 1
- 108010017312 CCR2 Receptors Proteins 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se refiere a compuestos de fórmula (1). Los compuestos actúan a través del antagonismo del receptor CCR2b y pueden utilizarse para tratar una enfermedad inflamatoria y/o el dolor neuropático. Reivindicación 1: 4-[(2R)-4-terc-butilpiperazina-2-carbonil]-N-(4-cloro-3-fluorofenil) piperazina-1-carboxamida como una base o una sal farmacéuticamente aceptable de la misma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12244508P | 2008-12-15 | 2008-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074737A1 true AR074737A1 (es) | 2011-02-09 |
Family
ID=42241254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090104853A AR074737A1 (es) | 2008-12-15 | 2009-12-14 | Derivados de (4-terc-butilpiperazin-2-il) (piperazin-1-il) metanona-n-carboxamida y composicion farmaceutica que los contiene |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US20100152197A1 (es) |
| EP (2) | EP2727913A1 (es) |
| JP (1) | JP2012512153A (es) |
| KR (1) | KR20110099012A (es) |
| CN (1) | CN102317273A (es) |
| AR (1) | AR074737A1 (es) |
| AU (1) | AU2009327575B2 (es) |
| BR (1) | BRPI0922439A2 (es) |
| CA (1) | CA2746990A1 (es) |
| CL (1) | CL2011001436A1 (es) |
| CO (1) | CO6440554A2 (es) |
| CR (1) | CR20110332A (es) |
| CU (1) | CU20110133A7 (es) |
| DO (1) | DOP2011000191A (es) |
| EA (1) | EA201190019A1 (es) |
| EC (1) | ECSP11011131A (es) |
| IL (1) | IL213163A0 (es) |
| MX (1) | MX2011006087A (es) |
| NI (1) | NI201100125A (es) |
| PE (1) | PE20120082A1 (es) |
| TW (1) | TW201028400A (es) |
| UY (1) | UY32321A (es) |
| WO (1) | WO2010071567A1 (es) |
| ZA (1) | ZA201105219B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7906645B2 (en) * | 2004-12-24 | 2011-03-15 | Astrazeneca Ab | Heterocyclic compounds as ccr2b antagonists |
| GB0525957D0 (en) * | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
| WO2018134731A1 (en) | 2017-01-17 | 2018-07-26 | Glaxosmithkline Intellectual Property Development Limited | Non peptidic heterobivalent molecules for treating inflammatory diseases |
| US12319958B2 (en) | 2020-07-21 | 2025-06-03 | Rutgers, The State University Of New Jersey | Method and kit for CCR2 expression profiling and disease stratification |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3133061A (en) * | 1962-11-13 | 1964-05-12 | Sterling Drug Inc | Piperidine carboxamides and derivatives thereof |
| US3541085A (en) * | 1969-05-09 | 1970-11-17 | American Cyanamid Co | Method of preparing thiotricyclic compounds |
| DE4234295A1 (de) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| NZ330868A (en) | 1996-02-13 | 2000-01-28 | Zeneca Ltd | 4-phenoxy, phenylthio or phenylamino substituted quinazoline derivatives ane medicaments useful as VEGF inhibitors |
| PT885198E (pt) | 1996-03-05 | 2002-06-28 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| DE19743435A1 (de) * | 1997-10-01 | 1999-04-08 | Merck Patent Gmbh | Benzamidinderivate |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| US7030123B2 (en) | 2000-05-31 | 2006-04-18 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| JP2004504391A (ja) | 2000-07-07 | 2004-02-12 | アンギオジェン・ファーマシューティカルズ・リミテッド | 血管新生阻害剤としてのコルキノール誘導体 |
| CN1255391C (zh) | 2000-07-07 | 2006-05-10 | 安吉奥金尼药品有限公司 | 作为血管破坏剂的colchinol衍生物 |
| WO2004110376A2 (en) | 2003-06-06 | 2004-12-23 | Merck & Co., Inc. | Ccr-2 antagonists for treatment of neuropathic pain |
| GB0428327D0 (en) * | 2004-12-24 | 2005-02-02 | Astrazeneca Ab | Method |
| US7906645B2 (en) * | 2004-12-24 | 2011-03-15 | Astrazeneca Ab | Heterocyclic compounds as ccr2b antagonists |
| GB0525957D0 (en) * | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
-
2009
- 2009-12-10 US US12/634,739 patent/US20100152197A1/en not_active Abandoned
- 2009-12-14 EP EP14153398.4A patent/EP2727913A1/en not_active Withdrawn
- 2009-12-14 AU AU2009327575A patent/AU2009327575B2/en not_active Ceased
- 2009-12-14 AR ARP090104853A patent/AR074737A1/es not_active Application Discontinuation
- 2009-12-14 JP JP2011540662A patent/JP2012512153A/ja active Pending
- 2009-12-14 CA CA2746990A patent/CA2746990A1/en not_active Abandoned
- 2009-12-14 UY UY0001032321A patent/UY32321A/es not_active Application Discontinuation
- 2009-12-14 KR KR1020117013597A patent/KR20110099012A/ko not_active Withdrawn
- 2009-12-14 EA EA201190019A patent/EA201190019A1/ru unknown
- 2009-12-14 CN CN2009801567238A patent/CN102317273A/zh active Pending
- 2009-12-14 TW TW098142762A patent/TW201028400A/zh unknown
- 2009-12-14 PE PE2011001229A patent/PE20120082A1/es not_active Application Discontinuation
- 2009-12-14 BR BRPI0922439A patent/BRPI0922439A2/pt not_active IP Right Cessation
- 2009-12-14 EP EP09833731A patent/EP2379519A4/en not_active Ceased
- 2009-12-14 MX MX2011006087A patent/MX2011006087A/es active IP Right Grant
- 2009-12-14 WO PCT/SE2009/051416 patent/WO2010071567A1/en active Application Filing
-
2011
- 2011-05-26 CO CO11065428A patent/CO6440554A2/es not_active Application Discontinuation
- 2011-05-26 IL IL213163A patent/IL213163A0/en unknown
- 2011-06-13 CL CL2011001436A patent/CL2011001436A1/es unknown
- 2011-06-15 NI NI201100125A patent/NI201100125A/es unknown
- 2011-06-15 EC EC2011011131A patent/ECSP11011131A/es unknown
- 2011-06-15 CU CU20110133A patent/CU20110133A7/es unknown
- 2011-06-15 DO DO2011000191A patent/DOP2011000191A/es unknown
- 2011-06-15 CR CR20110332A patent/CR20110332A/es not_active Application Discontinuation
- 2011-07-14 ZA ZA2011/05219A patent/ZA201105219B/en unknown
-
2012
- 2012-07-25 US US13/557,559 patent/US20120289513A1/en not_active Abandoned
-
2013
- 2013-06-27 US US13/928,803 patent/US20130289043A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120289513A1 (en) | 2012-11-15 |
| CN102317273A (zh) | 2012-01-11 |
| ECSP11011131A (es) | 2011-07-29 |
| AU2009327575A1 (en) | 2011-06-23 |
| NI201100125A (es) | 2012-03-19 |
| CU20110133A7 (es) | 2012-01-31 |
| WO2010071567A1 (en) | 2010-06-24 |
| IL213163A0 (en) | 2011-07-31 |
| MX2011006087A (es) | 2011-06-21 |
| CO6440554A2 (es) | 2012-05-15 |
| EP2379519A1 (en) | 2011-10-26 |
| EP2727913A1 (en) | 2014-05-07 |
| CA2746990A1 (en) | 2010-06-24 |
| US20130289043A1 (en) | 2013-10-31 |
| CR20110332A (es) | 2011-08-05 |
| KR20110099012A (ko) | 2011-09-05 |
| TW201028400A (en) | 2010-08-01 |
| ZA201105219B (en) | 2012-03-28 |
| CL2011001436A1 (es) | 2011-08-26 |
| EP2379519A4 (en) | 2012-06-20 |
| EA201190019A1 (ru) | 2012-02-28 |
| DOP2011000191A (es) | 2011-07-15 |
| UY32321A (es) | 2010-07-30 |
| BRPI0922439A2 (pt) | 2017-06-06 |
| PE20120082A1 (es) | 2012-03-04 |
| AU2009327575B2 (en) | 2013-07-04 |
| US20100152197A1 (en) | 2010-06-17 |
| JP2012512153A (ja) | 2012-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20110145A7 (es) | Derivados de sulfonamida | |
| SV2011004077A (es) | Derivados aminobutiricos sustituidos como inhibidores de neprilisina | |
| ECSP099706A (es) | Nuevos derivados de n-(8-heteroariltetrahidronaftalen-2yl) y n-(5-heteroarilcroman-3-il) carboxamida para el tratamiento del dolor | |
| CO6470866A2 (es) | Enantiómeros de compuestos de espirooxindol y sus usos como agentes terapéuticos. | |
| CL2009000394A1 (es) | Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
| MX383686B (es) | Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn. | |
| SV2009003400A (es) | Derivados de piridina | |
| CU20110217A7 (es) | Derivados amino-propiónicos sustituidos como inhibidores de neprilisina | |
| CO6480931A2 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas. | |
| CU20150014A7 (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| ECSP088747A (es) | Pirazoles como inhibidores de la 11-beta-hsd1 | |
| UY30809A1 (es) | Derivados de n-[3-[4-fenil)piperidin-1-carbonil]fenil]sulfonamidas sustituidas, procesos de preparacion y aplicaciones | |
| CO6690768A2 (es) | Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7 | |
| AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
| AR076300A1 (es) | Derivados de pirimidin imidazoles sustituidos, inhibidores de gsk3, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento del alzheimer, enfermedades neurodegenerativas agudas, diabetes y otras enfermedades. | |
| AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
| DOP2011000134A (es) | Lactamas como inhibidores de beta secretasa | |
| UY31672A1 (es) | "agonistas de receptores muscarínicos composiciones farmacéuticas métodos de tratamiento de los mismos, y procedimientos para su preparación" | |
| CR9722A (es) | Derivados de benzilpiperazina y su uso medico | |
| UY37837A (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| PE20151607A1 (es) | Formulaciones de compuestos organicos | |
| AR080172A1 (es) | (r) -4- ((4-((4-(tetrahidrofuran-3-iloxi) benzo (d) isoxazol-3-iloxi)metil)piperidin-1-il)metil) tetrahidro-2h-piran-4-ol, un agonista parcial de receptores 5-ht4 y composiciones farmaceuticas que los comprenden | |
| AR071721A1 (es) | Derivados de piridil-prolinamida, composiciones farmaceuticas que los contienen y su uso para el tratamiento de ansiedad, depresion y trastornos del sueno. | |
| AR074737A1 (es) | Derivados de (4-terc-butilpiperazin-2-il) (piperazin-1-il) metanona-n-carboxamida y composicion farmaceutica que los contiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |